Archive
Health Law Highlights
How AI Is Enhancing Health Care
Summary of article from Dallas Morning News, by James B. Milliken: The University of Texas System is embracing the potential of artificial intelligence (AI) in healthcare,…
AI, Health Care, and the Realities of Being Human
Summary of article from Undark, by Arjun V.K. Sharma: The “doorknob phenomenon” in medicine refers to patients revealing their most pressing concerns just as the doctor…
Healthcare Ransomware Attacks Lead to Uptick in ED Visits at Nearby Hospitals
Summary of article from Health IT Security, by Jill McKeon: A research letter in JAMA has revealed that ransomware attacks on hospitals not only disrupt the…
Why Physicians Are Ditching Their 9-5
Summary of article from D Magazine, by Will Maddox: A recent survey by AMN Healthcare reveals that nearly half of physicians and advanced practice providers find…
Accelerated Approval Process Is Not Without Risk: Placing Recent FDA Action in Context
Summary of article from Troutman Pepper, by Kyle Dolinsky, Judith O’Grady: The FDA withdrew approval for Pepaxto, a multiple myeloma drug, after post-marketing studies failed to…
Using A Value-Based Enterprise to Integrate Specialists and Primary Care: Taking Value-Based Care to the Next Level
Summary of article from Nelson Mullins Riley & Scarborough LLP, by Mike Segal, Edward White: Within the value-based healthcare model, the majority of medical expenses come…
Concurrent Call Coverage: Key Considerations for a Compliant Structure
Summary of article from VMG Health, by Holden Godat, CVA, Taylor Harville, Trent Fritzsche: Concurrent call coverage, where a physician provides on-call services to multiple locations…
D.C. Circuit Holds 340B Program Does Not Prohibit Drug Manufacturers from Imposing Contract Pharmacy Restrictions
Summary of article from Foley Hoag LLP, by Patrick Brennan, Andrew London, Ross Margulies, Kian Azimpoor: On May 21, 2024, the U.S. Court of Appeals for…
How State-Level Psychedelic Medicine Legislation Raises Equity Concerns
Summary of article from Healthcare Brew, by Maia Anderson: The FDA is likely to decide on the approval of an MDMA-based psychedelic medicine this year, with…
Louisiana Lawmakers Pass Bill Making Abortion Pills Controlled Dangerous Substances
Summary of article from AP News, by Sara Cline: Louisiana is set to reclassify abortion-inducing drugs, mifepristone and misoprostol, as controlled and dangerous substances under a…